Anemia and reversible reticulocytopenia associated with extended quinupristin/dalfopristin.
Evans
Pamela C
PC
Almas
James P
JP
Criddle
Frank J
FJ
D000328:Adult; D000740:Anemia / Q000139:chemically induced*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006621:Hip Joint / Q000382:microbiology; D006801:Humans; D008297:Male; D012156:Reticulocytes / Q000187:drug effects*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013211:Staphylococcus aureus; D014769:Virginiamycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014769:Virginiamycin; C062940:quinupristin-dalfopristin